-
cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin%20and%20SSRIs%20Graph%20V.%205.pdf
May 18, 2020 - Warfarin
Type of
Antidepressant
Assess risk and
take action if
necessary
Increased … GI and
non-GI bleeding
risk is possible
Assess risk and
take action if
necessary
Increased GI … and
non-GI bleeding
risk is possible
No special
precautions
Increased
bleeding risk
unlikely … No Yes
Use only if
benefit
outweighs risk
Increased GI and
non-GI bleeding
risk is likely
-
cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin%20and%20NSAIDs%20V.8.pdf
September 08, 2020 - And
Yes No
Assess risk and take
action if necessary
Possible increased risk
of bleeding Is patient … Yes
Start patient on proton
pump inhibitor
Assess risk and take
action if necessary
Possible increased … risk of bleeding
No
Use NSAIDS only if
benefit outweighs risk
Increased bleeding risk
likely
-
cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin-Antidepressants%20MDIA%20Implementation%20Guide.docx
August 29, 2020 - Warfarin – Antidepressants rule:
· Recommendation: Use only if benefit outweighs risk
· Rationale: Increased … Tablet
Mirtazapine 45 MG Disintegrating Oral Tablet
N/A
Assess risk and take action if necessary
Increased … 10 MG Oral Tablet
Escitalopram 20 MG Oral Tablet
None
Assess risk and take action if necessary
Increased … 10 MG Oral Tablet
Escitalopram 20 MG Oral Tablet
None
Assess risk and take action if necessary
Increased … Tablet
Systemic Corticosteroid = Prednisone 5 MG Oral Tablet
Use only if benefit outweighs risk
Increased
-
cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin-NSAIDs%20MDIA%20Implementation%20Guide.docx
November 11, 2019 - Omeprazole 40 MG Delayed Release Oral Capsule
Assess risk and take action if necessary
Possible increased … MG Oral Tablet
Sulindac 200 MG Oral Tablet
N/A
Assess risk and take action if necessary
Possible increased … MG Oral Tablet
Sulindac 200 MG Oral Tablet
N/A
Assess risk and take action if necessary
Possible increased … Ketorolac Tromethamine 10 MG Oral Tablet
N/A
Assess risk and take action if necessary
Possible increased … Ketorolac Tromethamine 10 MG Oral Tablet
N/A
Assess risk and take action if necessary
Possible increased
-
cds.ahrq.gov/sites/default/files/cds/artifact/106/HWI_2017.pptx
January 01, 2017 - Appropriate lipid screening orders increased from 43% to 56% among overweight and obese patients. … Discussion
Financial incentives and automation of weight status documentation immediately preceded increased
-
cds.ahrq.gov/sites/default/files/cds/artifact/logic/2024-02/Wernli%20Recommendations_1.txt
January 01, 2024 - Breast MRI results in increased biopsy and subsequent cancer detection rate relative to mammography alone
-
cds.ahrq.gov/sites/default/files/cds/artifact/106/Poster_AAPNCE_10.26.15.pptx
January 01, 1970 - Variations in care can result in increased healthcare cost without increased quality of patient care.
-
cds.ahrq.gov/sites/default/files/cds/artifact/632326/Flowchart_Wernli_new.pdf
April 03, 2024 - Breast MRI
results in increased biopsy and subsequent cancer detec2on rate rela2ve
to mammography
-
cds.ahrq.gov/sites/default/files/cds/artifact/136331/Bisphosphonates%20Patient%20Handout.pdf
July 18, 2023 - osteopenia or
osteoporosis, which are conditions associated with thin or fragile bones that are
at increased
-
cds.ahrq.gov/sites/default/files/cds/artifact/66551/Bisphosphonates%20Patient%20Handout.pdf
July 18, 2023 - osteopenia or
osteoporosis, which are conditions associated with thin or fragile bones that are
at increased
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_USPSTF%20Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_Final.docx
October 01, 2017 - of CVD and CRC in adults aged 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased … Persons who are not at increased risk for bleeding, have a life expectancy of at least 10 years, and … Defer the threshold values for lab tests that indicate increased bleeding risks, such as INR and platelet … Persons who are not at increased risk for bleeding, have a life expectancy of at least 10 years, and … Consider completeness
Lab values to represent increased risk of bleeding as an Exclusion
Usually lab
-
cds.ahrq.gov/sites/default/files/workgroups/34806/CDS_Connect_WG_October_2021_Summary.pdf
January 01, 2021 - would enable users to locate and understand
the contents of artifacts, which in turn could lead to increased
-
cds.ahrq.gov/sites/default/files/workgroups/58631/CDS_Connect_WG_February_2022_Summary.pdf
January 01, 2022 - The feasibility pilot also conducted interviews with seven patients, all of whom
reported increased … is allowing providers to see more patients,
both by the convenience of remote consultation and in increased
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/2024_CDS_Connect_IG_Aspirin_Therapy.pdf
January 01, 2024 - of CVD in adults aged 40 to 59 years who have a 10 percent
or greater 10-year CVD risk, are not at increased … Persons who are not at increased risk for bleeding and are willing to take low-dose aspirin
daily for … any dose)
OR ordered for or receiving palliative care
14
OR aspirin allergy
OR evidence of increased … full recommendation statements (2016 and 2022 together) named the following conditions
as carrying an increased … 18
Decision
Category
Concept Rationale
Consider
completeness
Lab values to represent increased
-
cds.ahrq.gov/cdsconnect/artifact/primary-care-management-guidance-fall-risk-increasing-drugs
June 08, 2022 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/workgroups/28166/CDS_Connect_WG_Slides_August%202021.pdf
August 01, 2021 - CEDAR is intended to increase the FAIRness of the PCOR findings in
AHRQ repositories
• To demonstrate increased
-
cds.ahrq.gov/taxonomy/term/11091
May 31, 2022 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/CDS_Connect_2024_Final_Report.pdf
January 01, 2024 - CDS Connect: Final Report 2024
CDS Connect: Final Report 2024
CDS Connect
Clinical Decision Support (CDS) Connect is a freely available, web-based platform that enable…
-
cds.ahrq.gov/sites/default/files/workgroups/1266/CDS_Connect_April2021_WG_Meeting_%20Summary.pdf
April 15, 2021 - CDS Connect Work Group Meeting Summary 4-15-2021
CDS (Clinical Decision Support) Connect Work Group
Meeting Summary
April 15, 2021
3:00 – 4:00 pm ET
Attendees: 44 people (41 attendees + 3 call-ins)
Organization Attendee Names
AHRQ Members Steve Bernstein, Roland Gamache, Ed Lomotan, Mary Nix, Mario …
-
cds.ahrq.gov/sites/default/files/workgroups/34806/CDS_Connect_WG_October_2021_Presentation.pdf
January 01, 2021 - October 2021 CDS Connect Work Group Call
October 2021 CDS Connect Work Group Call
Agenda
Schedule Topic
3:00 - 3:02 Roll Call, Michelle Lenox (MITRE)
3:02 - 3:05 Review of the Agenda, Maria Michaels (CDC)
3:05 - 3:50 Share and Discuss CDS Connect Priorities through September 2022,
Lacy Fabian (MITRE)
3:50 - …